These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 27194100)

  • 1. Integrative functional genomic delineation of the cascades of transcriptional changes involved in hepatocellular carcinoma progression.
    Ramesh V; Ganesan K
    Int J Cancer; 2016 Oct; 139(7):1586-97. PubMed ID: 27194100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative functional genomic analysis unveils the differing dysregulated metabolic processes across hepatocellular carcinoma stages.
    Ramesh V; Ganesan K
    Gene; 2016 Aug; 588(1):19-29. PubMed ID: 27107678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative analysis of transcriptome and miRNome unveils the key regulatory connections involved in different stages of hepatocellular carcinoma.
    Ramesh V; Ganesan K
    Genes Cells; 2016 Sep; 21(9):949-65. PubMed ID: 27465470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The HOX gene network in hepatocellular carcinoma.
    Cillo C; Schiavo G; Cantile M; Bihl MP; Sorrentino P; Carafa V; D' Armiento M; Roncalli M; Sansano S; Vecchione R; Tornillo L; Mori L; De Libero G; Zucman-Rossi J; Terracciano L
    Int J Cancer; 2011 Dec; 129(11):2577-87. PubMed ID: 21626505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative transcriptome analysis of liver cancer profiles identifies upstream regulators and clinical significance of ACSM3 gene expression.
    Gopal R; Selvarasu K; Pandian PP; Ganesan K
    Cell Oncol (Dordr); 2017 Jun; 40(3):219-233. PubMed ID: 28390038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptomic analysis of a transgenic zebrafish hepatocellular carcinoma model reveals a prominent role of immune responses in tumour progression and regression.
    Li Z; Luo H; Li C; Huo X; Yan C; Huang X; Al-Haddawi M; Mathavan S; Gong Z
    Int J Cancer; 2014 Oct; 135(7):1564-73. PubMed ID: 24550086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the mechanism of hepatocellular carcinoma progression by constructing genetic and epigenetic networks using NGS data identification and big database mining method.
    Li CW; Chang PY; Chen BS
    Oncotarget; 2016 Nov; 7(48):79453-79473. PubMed ID: 27821810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative Genomic Analysis Identifies the Core Transcriptional Hallmarks of Human Hepatocellular Carcinoma.
    Allain C; Angenard G; Clément B; Coulouarn C
    Cancer Res; 2016 Nov; 76(21):6374-6381. PubMed ID: 27634755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene network analysis leads to functional validation of pathways linked to cancer cell growth and survival.
    Berger E; Vega N; Vidal H; Geloën A
    Biotechnol J; 2012 Nov; 7(11):1395-404. PubMed ID: 22930530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse genomic alterations and stemness features are induced by field cancerization in the microenvironment of hepatocellular carcinomas.
    Castven D; Fischer M; Becker D; Heinrich S; Andersen JB; Strand D; Sprinzl MF; Strand S; Czauderna C; Heilmann-Heimbach S; Roessler S; Weinmann A; Wörns MA; Thorgeirsson SS; Galle PR; Matter MS; Lang H; Marquardt JU
    Oncotarget; 2017 Jul; 8(30):48688-48700. PubMed ID: 28415775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NFκB activation demarcates a subset of hepatocellular carcinoma patients for targeted therapy.
    Ramesh V; Selvarasu K; Pandian J; Myilsamy S; Shanmugasundaram C; Ganesan K
    Cell Oncol (Dordr); 2016 Dec; 39(6):523-536. PubMed ID: 27562587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative and integrative functional genomics of HCC.
    Lee JS; Thorgeirsson SS
    Oncogene; 2006 Jun; 25(27):3801-9. PubMed ID: 16799621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of hepatocellular carcinoma and cirrhosis gene expression profiles.
    Jiang M; Zeng Q; Dai S; Liang H; Dai F; Xie X; Lu K; Gao C
    Mol Med Rep; 2017 Jan; 15(1):380-386. PubMed ID: 27959423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive molecular and immunological characterization of hepatocellular carcinoma.
    Shimada S; Mogushi K; Akiyama Y; Furuyama T; Watanabe S; Ogura T; Ogawa K; Ono H; Mitsunori Y; Ban D; Kudo A; Arii S; Tanabe M; Wands JR; Tanaka S
    EBioMedicine; 2019 Feb; 40():457-470. PubMed ID: 30598371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of gene expression profiles identifies differential biomarkers for hepatocellular carcinoma and cholangiocarcinoma.
    Likhitrattanapisal S; Tipanee J; Janvilisri T
    Tumour Biol; 2016 Sep; 37(9):12755-12766. PubMed ID: 27448818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrative network analysis identifies key genes and pathways in the progression of hepatitis C virus induced hepatocellular carcinoma.
    Zheng S; Tansey WP; Hiebert SW; Zhao Z
    BMC Med Genomics; 2011 Aug; 4():62. PubMed ID: 21824427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated expression of cellular SYNE1, MMP10, and GTPase1 and their regulatory role in hepatocellular carcinoma progression.
    Faraj Shaglouf LH; Ranjpour M; Wajid S; Jain SK
    Protoplasma; 2020 Jan; 257(1):157-167. PubMed ID: 31428857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic copy number alterations with transcriptional deregulation at 6p identify an aggressive HCC phenotype.
    Kwon SM; Kim DS; Won NH; Park SJ; Chwae YJ; Kang HC; Lee SH; Baik EJ; Thorgeirsson SS; Woo HG
    Carcinogenesis; 2013 Jul; 34(7):1543-50. PubMed ID: 23508637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional and topological properties in hepatocellular carcinoma transcriptome.
    Drozdov I; Bornschein J; Wex T; Valeyev NV; Tsoka S; Malfertheiner P
    PLoS One; 2012; 7(4):e35510. PubMed ID: 22539975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity.
    Moeini A; Sia D; Zhang Z; Camprecios G; Stueck A; Dong H; Montal R; Torrens L; Martinez-Quetglas I; Fiel MI; Hao K; Villanueva A; Thung SN; Schwartz ME; Llovet JM
    J Hepatol; 2017 May; 66(5):952-961. PubMed ID: 28126467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.